Williams R C, Malone C C, Silvestris F
Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Florida, Gainesville 32610, USA.
Clin Immunol Immunopathol. 1996 Aug;80(2):194-203. doi: 10.1006/clin.1996.0114.
Affinity-isolated IgG anti-F(ab')2 (APAF) and anti-DNA (APAD) from normal subjects as well as patients with systemic lupus erythematosus (SLE) were studied for overlapping antibody specificities as well as shared V-region antigens using rabbit antisera prepared against F(ab')2 fragments of SLE IgG APAD or IgG APAF from normal individuals. When absorbed free of antibody reacting with normal human IgG, both types of rabbit anti-Ids showed cross-reacting antigenic determinants shared by APAF and APAD from both normals and SLE patients. Immunodepletion of APAD or APAF IgG fractions using immunoabsorbents composed of such rabbit anti-SLE F(ab')2 APAD or anti-normal IgG APAF antibodies produced substantial decrements (40-90%) in ELISA anti-F(ab')2, antiSm, anti-Sm/RNP, and anti-DNA reactivity. Parallel decrements in human anti-DNA Id markers F4 and 3I were also recorded after immunoadsorbent depletions of SLE APADs. Absorption of rabbit IgG anti-SLE APAD F(ab')2 antibody with DNA-Sepharose produced a relative increment in ELISA anti-DNA reactivity but a marked parallel decrement in reactivity for the original SLE APAD immunogen. Eluates from DNA-Sepharose contained rabbit epibody showing moderate anti-DNA affinity and high-affinity anti-APAD idiotypic activity. This epibody fraction showed relative concentration of rabbit IgG antibodies capable of blocking combining sites of SLE IgG APAD reacting with DNA on the ELISA plate. Our findings indicate a previously unexpected close antigenic and specificity overlap between human IgG anti-F(ab')2 and anti-DNA antibodies. Moreover, they emphasize a surprising relative infrequency of anti-DNA idiotypic antibodies capable of blocking combining sites in animals immunized with SLE F(ab')2 APAD. This finding may relate to an intrinsic defect of anti-Id regulation in SLE.
研究了从正常受试者以及系统性红斑狼疮(SLE)患者中亲和分离得到的抗F(ab')2(APAF)和抗DNA(APAD)IgG,利用针对正常个体的SLE IgG APAD或IgG APAF的F(ab')2片段制备的兔抗血清,研究其重叠抗体特异性以及共享的V区抗原。当去除与正常人IgG反应的抗体后,两种兔抗独特型抗体均显示出正常人和SLE患者的APAF和APAD共有的交叉反应性抗原决定簇。使用由这种兔抗SLE F(ab')2 APAD或抗正常IgG APAF抗体组成的免疫吸附剂对APAD或APAF IgG组分进行免疫去除,可使ELISA中抗F(ab')2、抗Sm、抗Sm/RNP和抗DNA反应性大幅降低(40 - 90%)。在用免疫吸附剂去除SLE APAD后,还记录到人类抗DNA独特型标志物F4和3I的平行降低。用DNA - 琼脂糖吸附兔抗SLE APAD F(ab')2抗体,可使ELISA抗DNA反应性相对增加,但对原始SLE APAD免疫原的反应性则明显平行降低。从DNA - 琼脂糖洗脱的物质中含有兔表位抗体,其显示出中等抗DNA亲和力和高亲和力抗APAD独特型活性。该表位抗体组分显示出能够阻断ELISA板上与DNA反应的SLE IgG APAD结合位点的兔IgG抗体相对富集。我们的研究结果表明,人类IgG抗F(ab')2和抗DNA抗体之间存在先前未预料到的紧密抗原和特异性重叠。此外,它们强调了在用SLE F(ab')2 APAD免疫的动物中,能够阻断结合位点的抗DNA独特型抗体相对罕见这一惊人发现。这一发现可能与SLE中抗独特型调节的内在缺陷有关。